Literature DB >> 21934722

Stem cells for myocardial regeneration.

M S Penn1, F Dong, S Klein, M E Mayorga.   

Abstract

The field of cardiovascular regenerative medicine has made significant strides over the past decade. Clinical trials have demonstrated benefit in acute myocardial infarction (AMI) and chronic heart failure (CHF). As the field has matured, it has defined novel biology and invented an array of therapeutic strategies that are currently under development. In this brief review, we attempt to conceptualize the knowledge to date as well as examine how this knowledge has been translated to various therapeutic strategies.

Entities:  

Mesh：

Year:  2011        PMID： 21934722     DOI： 10.1038/clpt.2011.196

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  8 in total

1.  Getting at the heart of the issue: advanced imaging and stem cell-based therapy offer a novel approach to cardiac resynchronization.

Authors:  S Wright; R Lakin; S Esfandiari
Journal:  J Physiol       Date:  2013-11-01       Impact factor: 5.182

2.  Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.

Authors:  Chika Kikuchi; Martin Bienengraeber; Scott Canfield; Andrew Koopmeiner; Richard Schäfer; Zeljko J Bosnjak; Xiaowen Bai
Journal:  Cell Transplant       Date:  2015-01-05       Impact factor: 4.064

Review 3.  Regenerative medicine: transforming the drug discovery and development paradigm.

Authors:  Sotirios K Karathanasis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

Review 4.  MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation.

Authors:  Moriel H Vandsburger; Marina Radoul; Batya Cohen; Michal Neeman
Journal:  NMR Biomed       Date:  2012-12-06       Impact factor: 4.044

Review 5.  Stem cell therapy for heart disease.

Authors:  Shannon B Puliafico; Marc S Penn; Kevin H Silver
Journal:  J Gen Intern Med       Date:  2013-06-15       Impact factor: 5.128

6.  Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct.

Authors:  Mónika Szepes; Zsófia Janicsek; Zsolt Benkő; Attila Cselenyák; Levente Kiss
Journal:  Int J Mol Med       Date:  2012-11-16       Impact factor: 4.101

7.  Efficacy and Safety of Stem Cell Therapy in Advanced Heart Failure Patients: A Systematic Review with a Meta-analysis of Recent Trials Between 2017 and 2019.

Authors:  Joseph S Jayaraj; Rajesh Naidu Janapala; Aisha Qaseem; Norina Usman; Nida Fathima; Tooba Kashif; Vineeth K Reddy; Sanjiv Bakshi
Journal:  Cureus       Date:  2019-09-06

8.  Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction.

Authors:  Satsuki Yamada; Timothy J Nelson; Garvan C Kane; Almudena Martinez-Fernandez; Ruben J Crespo-Diaz; Yasuhiro Ikeda; Carmen Perez-Terzic; Andre Terzic
Journal:  J Physiol       Date:  2013-04-08       Impact factor: 5.182
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.